© 2017 by Karen Edelblum

Edelblum Lab

 IBD research laboratory at Rutgers studying immune/epithelial interactions to better understand the underlying causes of Crohn's disease and discover potential new areas for therapeutic development

  • LinkedIn - White Circle
  • Twitter - White Circle


3.1 million Americans


Crohn's disease and ulcerative colitis affect 1.3% of the population with 70,000 new cases diagnosed every year. IBD is caused by a combination of genetic and environmental factors that lead to an abnormal immune reaction to the normal bacteria found in the intestine.



Postdoc position available

Do you have expertise in human immunology, transcriptomics and/or IBD research? We are looking for a highly motivated, dynamic individual to join our lab to work on IELs in IBD.

September 16, 2019

Maddie takes home a #FASEBGI2019 Best Poster Award!

Maddie's poster on the role of CD103 and gamma delta IELs in epithelial shedding was one of five recognized for their outstanding presentation.

July 29, 2019

Edelblum Lab participates in TakeSteps 2019

Team Two-Ply Minimum raises over $2,500 for IBD research!

June 09, 2019

JoVE article on intravital imaging

Congrats to Luo (Jack) Jia on the publication of his article in JoVE!

June 01, 2019

Please reload



  • White Twitter Icon
  • LinkedIn - White Circle